Pi3k/mtor dual inhibitor pf-04691502 is a schedule-dependent radiosensitizer for gastroenteropancreatic neuroendocrine tumors

Zeta Chow, Jeremy Johnson, Aman Chauhan, Tadahide Izumi, Michael Cavnar, Heidi Weiss, Courtney M. Townsend, Lowell Anthony, Carrigan Wasilchenko, Matthew L. Melton, Jörg Schrader, B. Mark Evers, Piotr Rychahou

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Pi3k/mtor dual inhibitor pf-04691502 is a schedule-dependent radiosensitizer for gastroenteropancreatic neuroendocrine tumors'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science